SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-23-002479
Filing Date
2023-02-14
Accepted
2023-02-14 17:15:22
Documents
1
Group Members
ATHOS KGDR. MATTHIAS HALLWEGERFCP BIOTECH HOLDING GMBHFCPB AFFI GMBHFIRST CAPITAL PARTNER GMBHHMW EMISSIONSHAUS AGHMW KOMPLEMENTAR GMBHHMW VERWALTUNGS GMBHMICHAEL MOTSCHMANNMIG ASSET TRUST GMBHMIG CAPITAL AGMIG GMBH & CO. FONDS 11 KG I.L.MIG GMBH & CO. FO

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 b26231sc13ga1.htm SC 13G/A 350784
  Complete submission text file 0001214659-23-002479.txt   353405
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Subject) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89853 | Film No.: 23631585
SIC: 2834 Pharmaceutical Preparations

Mailing Address KARL FARKAS GASSE 22 VIENNA C4 1030
Business Address KARL FARKAS GASSE 22 VIENNA C4 1030 0043 1 798 15 75 300
AFFIRIS AG in Liqu (Filed by) CIK: 0001876820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 13G/A